1. Home
  2. DDL vs INDP Comparison

DDL vs INDP Comparison

Compare DDL & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dingdong (Cayman) Limited (each two representing three)

DDL

Dingdong (Cayman) Limited (each two representing three)

HOLD

Current Price

$1.93

Market Cap

494.2M

ML Signal

HOLD

Logo Indaptus Therapeutics Inc.

INDP

Indaptus Therapeutics Inc.

HOLD

Current Price

$3.41

Market Cap

438.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DDL
INDP
Founded
2014
2000
Country
China
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
494.2M
438.4M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
DDL
INDP
Price
$1.93
$3.41
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
222.9K
★ 403.7K
Earning Date
11-11-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$15.28
N/A
Revenue Next Year
$9.66
N/A
P/E Ratio
$16.08
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.65
$0.92
52 Week High
$3.41
$5.96

Technical Indicators

Market Signals
Indicator
DDL
INDP
Relative Strength Index (RSI) 32.00 60.54
Support Level $1.86 $2.05
Resistance Level $2.65 $3.84
Average True Range (ATR) 0.07 0.33
MACD -0.02 0.07
Stochastic Oscillator 7.14 91.97

Price Performance

Historical Comparison
DDL
INDP

About DDL Dingdong (Cayman) Limited (each two representing three)

Dingdong (Cayman) Ltd are a foremost fresh grocery e-commerce company in mainland China with sustainable growth. It directly provide users and households with fresh groceries, prepared food and other food products through delivering a convenient and excellent shopping experience supported by an extensive self-operated frontline fulfillment grid. The Group operates and manages its business as a single segment. The Group generates substantially all of its revenues from customers in the PRC.

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a clinical biotechnology company that has developed a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. Its approach is based on the hypothesis that efficient activation of both innate and adaptive immune cells and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system activating signals that can be administered safely intravenously. Its patented technology is composed of single strains of attenuated and killed, non-pathogenic, Gram-negative bacteria, designed to have reduced i.v. toxicity, but largely uncompromised ability to prime or activate many of the cellular components of innate and adaptive immunity. Its candidate, Decoy20 is for patients with solid tumors.

Share on Social Networks: